Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
Life Sciences
|
January 1, 1988
Active immunization to luteinizing hormone releasing hormone to inhibit the induction of mammary tumors in the rat
P M Ravdin, V C Jordan
Breast Cancer Research and Treatment
|
January 1, 1992
A practical application of neural network analysis for predicting outcome of individual breast cancer patients
P M Ravdin, G M Clark
Cancer
|
July 1, 1994
Prognostic factors in early breast carcinoma
E G Mansour, P M Ravdin, L Dressler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy
P M Ravdin, I A Siminoff, J A Harvey
Breast Cancer Research and Treatment
|
January 1, 1987
Estrogenic effects of phenolphthalein on human breast cancer cells in vitro
P M Ravdin, M van Beurden, V C Jordan
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 1, 1981
Internalization of alpha-bungarotoxin on neurons induced by a neurotoxin that blocks neuronal acetylcholine sensitivity
P M Ravdin, R M Nitkin, D K Berg
Investigational New Drugs
|
January 1, 1994
Phase II trial of piroxantrone in metastatic breast cancer. A Southwest Oncology Group study
P M Ravdin, S Green, J H Doroshow, et al.
Journal of the National Cancer Institute
|
December 7, 1994
Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators
P M Ravdin, M De Laurentiis, T Vendely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1994
Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer?
C L Loprinzi, P M Ravdin, M de Laurentiis, et al.
Cancer Research
|
February 15, 1988
Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen
P M Ravdin, N F Fritz, D C Tormey, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
Life Sciences
|
January 1, 1988
Active immunization to luteinizing hormone releasing hormone to inhibit the induction of mammary tumors in the rat
P M Ravdin, V C Jordan
Breast Cancer Research and Treatment
|
January 1, 1992
A practical application of neural network analysis for predicting outcome of individual breast cancer patients
P M Ravdin, G M Clark
Cancer
|
July 1, 1994
Prognostic factors in early breast carcinoma
E G Mansour, P M Ravdin, L Dressler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy
P M Ravdin, I A Siminoff, J A Harvey
Breast Cancer Research and Treatment
|
January 1, 1987
Estrogenic effects of phenolphthalein on human breast cancer cells in vitro
P M Ravdin, M van Beurden, V C Jordan
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 1, 1981
Internalization of alpha-bungarotoxin on neurons induced by a neurotoxin that blocks neuronal acetylcholine sensitivity
P M Ravdin, R M Nitkin, D K Berg
Investigational New Drugs
|
January 1, 1994
Phase II trial of piroxantrone in metastatic breast cancer. A Southwest Oncology Group study
P M Ravdin, S Green, J H Doroshow, et al.
Journal of the National Cancer Institute
|
December 7, 1994
Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators
P M Ravdin, M De Laurentiis, T Vendely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1994
Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer?
C L Loprinzi, P M Ravdin, M de Laurentiis, et al.
Cancer Research
|
February 15, 1988
Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen
P M Ravdin, N F Fritz, D C Tormey, et al.
Page
of 6